This metabolic pathway, discovered by us and referred to as the NGF metabolic cascade, is described in detail in this review along with its marked dysregulation in the Alzheimer’s disease (AD) pathology. This evidence concerns the gene NGF and early-onset autosomal dominant Alzheimer disease.